Skip to main content

Table 3 Characteristics and outcome of the three children hospitalized for a diagnosis of MIS-C

From: Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups

Subject

Age (y)

Sex

Symptoms

Cardiac involvement (Yes/No)

sHLH/MAS

Blood exams

Therapy

Length of hospitalization (days)

Outcome

1

2

F

Fever, pharyngitis, anorexia, vomit, rash

No

No

CRP 10.4 mg/dL, ESR 73 mm/h, ferritin 207 ug/L, fibrinogen 609 mg/L, proBNP II 4032 ng/L, D-dimer 4549 ug/L, albumin 3.1 g/dL

Oral steroid, IVIg, ASA, PPI, cefotaxime

14

Recovery without sequelae

2

3

M

Fever, conjunctival hyperemia, anorexia

No

No

CRP 12.9 mg/dL, ferritin 536 ug/L, fibrinogen 333 mg/L, TnT 3 ng/L proBNP II 2998 ng/L, D-dimer 5326 ug/L

IVIg, ASA, PPI, ceftriaxone

11

Recovery without sequelae

3

8

F

Fever, diarrhea, vomit, pharyngitis, oral mucositis, conjunctival hyperemia, abdominal pain, headache

No

No

CRP 9.17 mg/dL, PCT 12.6 ug/L, ferritin 477 ug/L, fibrinogen 599 mg/L, TnT 3 ng/L proBNP II 118 ng/L, D-dimer 4911 ug/L, albumin 2.99 g/dL

IVIg, IV high-dose steroid, ASA, PPI, ceftriaxone, piperacillin/tazobactam

14

Recovery without sequelae

  1. CRP C-reactive Protein, PCT Procalcitonin, ESR Erythrocyte sedimentation rate, IL-6 Interleukin-6, TnT Troponin T, proBNP II Terminal pro-brain natriuretic peptide, LDH Lactate dehydrogenase, IVIg Intravenous immunoglobulin, IV Intravenous, ASA Acetylsalicylic acid, PPI Proton-pump inhibitors